China to India: Syringe Import Trade Route
India has recorded 7 verified shipments of Syringe imported from China, representing a combined trade value of $478.6K USD. This corridor is served by 3 active China exporters, with an average shipment value of $68.4K USD. The leading China supplier is YUXI WALVAX BIOTECHNOLOGY CO., LTD., which accounts for 97% of total import value with 2 shipments worth $464.5K USD. On the buying side, G.C. CHEMIE PHARMIE LIMITED is the largest Indian importer with $464.5K USD in purchases. The top 3 suppliers — YUXI WALVAX BIOTECHNOLOGY CO., LTD., HUBEI NEW DESHENG MATERIALS , Tianjin Apocalypse Trading Company — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The China to India Syringe corridor is one of India's established pharmaceutical import routes from China, with 7 shipments documented worth a combined $478.6K USD. The route is dominated by YUXI WALVAX BIOTECHNOLOGY CO., LTD., which alone accounts for roughly 97% of all import value, reflecting the consolidated nature of China's syringe export sector.
Across 3 active China suppliers, the average shipment value stands at $68.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with syringe's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.1%, placing it at rank #18 among India's top syringe import origins globally.
On the Indian buyer side, key Indian importers include G.C. CHEMIE PHARMIE LIMITED, POLY MEDICURE LIMITED , MYLAN LABORATORIES LIMITED . G.C. CHEMIE PHARMIE LIMITED is the single largest Indian importer with 2 shipments valued at $464.5K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entryN?A
Market Position
- Global rank#18
- Annual growth+30.1%
- Demand growth+27.0%
- Regulatory ease84/100
Top 10 Syringe Exporters from China to India
Showing top 10 of 3 China suppliers exporting Syringe to India, ranked by total trade value (USD)
| Rank | Supplier (China Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | YUXI WALVAX BIOTECHNOLOGY CO., LTD. Avg $232.3K per shipment | 2 | $464.5K | 97.1% |
| 2 | HUBEI NEW DESHENG MATERIALS Avg $3.1K per shipment | 3 | $9.4K | 2.0% |
| 3 | Tianjin Apocalypse Trading Company Avg $2.3K per shipment | 2 | $4.7K | 1.0% |
This table shows the top 10 of 3 China companies exporting syringe to India, ranked by total trade value. The listed exporters are: YUXI WALVAX BIOTECHNOLOGY CO., LTD., HUBEI NEW DESHENG MATERIALS , Tianjin Apocalypse Trading Company . YUXI WALVAX BIOTECHNOLOGY CO., LTD. is the dominant supplier with 2 shipments worth $464.5K USD, giving it a 97% market share.
Top 10 Indian Syringe Importers from China
Showing top 10 of 3 known Indian buyers receiving Syringe shipments from China, ranked by import value
On the receiving end of this trade route, the leading Indian importers of China syringe include G.C. CHEMIE PHARMIE LIMITED, POLY MEDICURE LIMITED , MYLAN LABORATORIES LIMITED . The largest importer is G.C. CHEMIE PHARMIE LIMITED, accounting for $464.5K USD across 2 shipments — representing 97% of all syringe imports from China on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | G.C. CHEMIE PHARMIE LIMITED | 2 | $464.5K | 97.1% |
| 2 | POLY MEDICURE LIMITED | 3 | $9.4K | 2.0% |
| 3 | MYLAN LABORATORIES LIMITED | 2 | $4.7K | 1.0% |
Top 10 Syringe Formulations Imported from China
Showing top 10 of 5 product formulations shipped on the China to India Syringe route, ranked by trade value
India imports a wide range of syringe formulations from China, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IP (QTY: 75000PRE-FILLED SYRINGES) — accounts for $463.6K USD across 1 shipments. A total of 5 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IP (QTY: 75000PRE-FILLED SYRINGES) | 1 | $463.6K | 96.9% |
| 2 | HEPARIN FOR BLOOD COLLECTION SYRINGE(LITHIUM HEPARIN) | 3 | $9.4K | 2.0% |
| 3 | Gadoxetate Sodium Injection EOB.Primovist Inj.Syringe - BATCH#JPS5805- QTY 5units (syringe) - 181.43mg/mL 10mL | 1 | $2.6K | 0.5% |
| 4 | Gadoxetate Sodium Injection EOB.Primovist Inj.Syringe - BATCH#JPS5386 - QTY 5units (syringe) - 181.43mg/mL 5mL | 1 | $2.0K | 0.4% |
| 5 | 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IP (QTY: 150 PRE-FILLED SYRINGES) (FREE OF CHARGE) | 1 | $927 | 0.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
N?A handles the highest volume with 5 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's syringe imports from China are driven primarily by a handful of large-scale China manufacturers. YUXI WALVAX BIOTECHNOLOGY CO., LTD. with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from China supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — YUXI WALVAX BIOTECHNOLOGY CO., LTD., HUBEI NEW DESHENG MATERIALS , Tianjin Apocalypse Trading Company — together account for 100% of total trade value on this route. The average shipment value of $68.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as heparin for blood collection syringe(lithium heparin) and gadoxetate sodium injection eob.primovist inj.syringe - batch#jps5805- qty 5units (syringe) - 181.43mg/ml 10ml , suggesting that Indian buyers tend to consolidate orders across related product lines from the same China supplier.
On the buying side, G.C. CHEMIE PHARMIE LIMITED is the largest importer with 2 shipments worth $464.5K USD — representing 97% of all syringe imports from China on this route.
Route Statistics
- Trade Volume
- $478.6K
- Avg. Shipment
- $68.4K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~23 days
- Annual Growth
- +30.1%
Unlock the Full China to India Syringe Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — China to India Syringe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which China companies export Syringe to India?
The leading China exporters of Syringe to India are YUXI WALVAX BIOTECHNOLOGY CO., LTD., HUBEI NEW DESHENG MATERIALS , Tianjin Apocalypse Trading Company . YUXI WALVAX BIOTECHNOLOGY CO., LTD. holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Syringe imports from China to India?
India imports Syringe from China worth approximately $478.6K USD across 7 recorded shipments. The average value per shipment is $68.4K USD.
Q Which Indian ports receive Syringe from China?
The most active Indian port of entry is N?A with 5 shipments. China exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from China to India for Syringe?
The average transit time for Syringe shipments from China to India is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the China to India Syringe import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.1% with demand growth tracking at 27.0%. The route is ranked #18 among India's top Syringe import origins globally.
Q How many China suppliers are active on this Syringe import route?
There are currently 3 active China suppliers exporting Syringe to India. The market is moderately concentrated with YUXI WALVAX BIOTECHNOLOGY CO., LTD. accounting for 97% of total shipment value.
Q Who are the main Indian importers of Syringe from China?
The leading Indian importers of Syringe from China include G.C. CHEMIE PHARMIE LIMITED, POLY MEDICURE LIMITED , MYLAN LABORATORIES LIMITED . G.C. CHEMIE PHARMIE LIMITED is the largest buyer with 2 shipments worth $464.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to China export trade corridor identified from Indian Customs (DGFT) records for Syringe.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in China matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists